Arno Therapeutics (Apristor Onapristone XR Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Arno Therapeutics (Apristor Onapristone XR Drug) General Information

Description

A therapeutic drug right in Pennsylvania, United States. The drug rights is associated with development of drugs for the treatment of breast cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 200 Route 31
  • No. 104
  • Flemington, NJ 08822
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Pharmaceuticals
Acquirer
Context Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 200 Route 31
  • No. 104
  • Flemington, NJ 08822
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arno Therapeutics (Apristor Onapristone XR Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arno Therapeutics (Apristor Onapristone XR Drug)‘s full profile, request access.

Request a free trial

Arno Therapeutics (Apristor Onapristone XR Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arno Therapeutics (Apristor Onapristone XR Drug)‘s full profile, request access.

Request a free trial

Arno Therapeutics (Apristor Onapristone XR Drug) FAQs

  • Where is Arno Therapeutics (Apristor Onapristone XR Drug) headquartered?

    Arno Therapeutics (Apristor Onapristone XR Drug) is headquartered in Flemington, NJ.

  • What industry is Arno Therapeutics (Apristor Onapristone XR Drug) in?

    Arno Therapeutics (Apristor Onapristone XR Drug)’s primary industry is Buildings and Property.

  • Is Arno Therapeutics (Apristor Onapristone XR Drug) a private or public company?

    Arno Therapeutics (Apristor Onapristone XR Drug) is a Private company.

  • What is Arno Therapeutics (Apristor Onapristone XR Drug)’s current revenue?

    The current revenue for Arno Therapeutics (Apristor Onapristone XR Drug) is .

  • Who are Arno Therapeutics (Apristor Onapristone XR Drug)’s investors?

    Arno Therapeutics has invested in Arno Therapeutics (Apristor Onapristone XR Drug).

  • When was Arno Therapeutics (Apristor Onapristone XR Drug) acquired?

    Arno Therapeutics (Apristor Onapristone XR Drug) was acquired on 15-Jan-2018.

  • Who acquired Arno Therapeutics (Apristor Onapristone XR Drug)?

    Arno Therapeutics (Apristor Onapristone XR Drug) was acquired by Context Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process